Two-year efficacy and safety of erenumab in participants with episodic migraine and 2–4 prior preventive treatment failures: results from the LIBERTY study

por Ferrari, Michel Dominique, Reuter, Uwe, Goadsby, Peter J, Paiva da Silva Lima, Gabriel, Mondal, Subhayan, Wen, Shihua, Tenenbaum, Nadia, Pandhi, Shaloo, Lanteri-Minet, Michel, Stites, Tracy
Publicado 2022